Dirk Blom

机构：University of Cape Town · ORCID：0000-0003-3965-5912

发表论文 254 篇 · 总被引 18492 次 · h-index 51

代表论文

• Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk (2025 · New England Journal of Medicine · 被引 50)
• Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: A systematic review and meta-analysis (2025 · PLoS ONE · 被引 30)
• Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial (2025 · The Lancet Diabetes & Endocrinology · 被引 24)
• Life Course Approach for Managing Familial Hypercholesterolemia (2025 · Journal of the American Heart Association · 被引 22)
• Homozygous Familial Hypercholesterolemia Treatment: New Developments (2025 · Current Atherosclerosis Reports · 被引 21)
• Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study (2024 · The Lancet Diabetes & Endocrinology · 被引 13)